Since the arrival of antiretroviral (ARV) therapy, HIV has become better characterized as a chronic disease rather than a terminal illness, depending in part on one's ability to maintain relatively high levels of adherence. Despite research concerning barriers and facilitators of ARV adherence behavior, relatively little is known about specific challenges faced by HIV-positive persons who report ''taking a break'' from their ARV medications. The present study employed the InformationÁMotivationÁBehavioral Skills Model of ARV adherence as a framework for understanding adherence-related barriers that may differentiate between non-adherent patients who report ''taking a break'' versus those who do not report ''taking a break'' from their ARV medications. A sample of 327 HIV-positive patients who reported less than 100% adherence at study baseline provided data for this research. Participants who reported ''taking a break'' from their HIV medications without first talking to their healthcare provider were classified as intentionally non-adherent, while those who did not report ''taking a break'' without first talking with their healthcare provider were classified as unintentionally non-adherent. Analyses examined differences between intentionally versus unintentionally non-adherent patients with respect to demographic characteristics and responses to the adherence-related information, motivation, and behavioral skills questionnaire items. Few differences were observed among the groups on demographics, adherence-related information, or adherence-related motivation; however, significant differences were observed on about half of the adherence-related behavioral skills items. Implications for future research, as well as the design of specific intervention components to reduce intentionally non-adherent behavior, are discussed.
Introduction
Since the introduction of antiretroviral (ARV) therapy, HIV has been transformed from a terminal illness to a manageable chronic disease (Quinn, 2008; Simon, Ho, & Abdool Karim, 2006) , contingent upon maintenance of relatively high levels of adherence (Chen, Hoy, & Lewin, 2007; Conway, 2007) . Correlates of optimal ARV adherence have been described among various HIV-positive populations (Halkitis, Shrem, Zade, & Wilton, 2005; Remien et al., 2003; Simoni, Amico, Pearson, & Malow, 2008a , 2008b , and this work has been essential for the development of interventions to help patients overcome adherence-related barriers, increase medication-taking behavior, and improve overall health status (Amico, Harman, & Johnson, 2006; Fisher et al., 2010; Mannheimer et al., 2006; Simoni, Amico, Smith, & Nelson, 2010; Simoni, Pearson, Pantalone, Marks, & Crepaz, 2006) .
Despite research concerning correlates of ARV adherence, however, relatively little is known about the specific adherence-related barriers faced by HIVpositive patients who are non-adherent and report ''taking a break'' from their ARV medication regimen. Although definitions of intentionally versus unintentionally non-adherent behavior vary across health domains, intentional non-adherence is generally characterized as the patient's conscious awareness of and decision not to adhere to one's regimen as prescribed, which may include periods of altering one's dose requirements or discontinuing one's medication altogether (Heath, Singer, O'Shaughnessy, Montaner, & Hogg, 2002; Mo & Mak, 2009; Wilson et al., 2009) . Unintentional non-adherence is generally characterized as missing doses or pills ''by mistake,'' or for reasons that are not consciously executed decisions (Heath et al., 2002; Mo & Mak, 2009; Wilson et al., 2009) . The conceptual distinction between intentional and unintentional non-adherence to medications has been examined in other literatures (e.g., hypertension, bipolar disorder, cancer; Atkins & Fallowfield, 2006; Clatworthy, Bowskill, Rank, Parham, & Horne, 2007; Lehane & McCarthy, 2007) , but has received relatively less attention within the ARV adherence domain (Mo & Mak, 2009) .
Differentiation between intentional and unintentional non-adherence Á and a better understanding of the potentially unique issues associated with each type of non-adherence Á is important in that it may offer critical insights to inform the design of interventions aimed at reducing such behavior. There is evidence to suggest that intentional versus unintentional non-adherent HIV-positive patients may struggle with different adherence-related barriers (e.g., cost of ARVs and managing side effects; Heath et al., 2002; Kumarasamy et al., 2005; Roberts & Mann, 2003; Wroe & Thomas, 2003) . However, little research has examined the particular psychosocial barriers that may distinguish intentional versus unintentional non-adherent HIV-positive patients. A noteworthy exception is a recent study conducted in Hong Kong by Mo and Mak (2009) , who found that intentional non-adherent HIV-positive patients reported greater use of avoidant coping strategies than unintentional non-adherent patients. Whether or not these findings may be replicated in a US population, and examination of an array of psychosocial barriers that may differentiate intentional versus unintentional non-adherers, however, has yet to occur.
The current research applied the InformationÁ MotivationÁBehavioral Skills (IMB) Model of ARV adherence (Fisher, Amico, Fisher, & Harman, 2008; Fisher, Fisher, Amico, & Harman, 2006) as a framework for understanding adherence-related barriers that may differentiate intentional and unintentional non-adherent HIV-positive patients. Briefly, the IMB model of ARV adherence posits that sub-optimal adherence results from deficits in adherence-related information, motivation, and behavioral skills. Adherence-related information includes factual knowledge about one's medications (e.g., understanding the potential drug interactions and side effects of one's medications; Fisher et al., 2006 Fisher et al., , 2008 , as well as misinformation and heuristics that would deter medication adherence (e.g., belief that ARVs are a government conspiracy to make people ill; Kalichman, 2009 ). Adherence-related motivation encom-passes personal motivation (e.g., attitudes toward taking one's medications; Fisher et al., 2006 Fisher et al., , 2008 and social motivation (e.g., social support for taking one's medications; Fisher et al., 2006 Fisher et al., , 2008 for adhering to one's ARV regimen. Adherence-related behavioral skills consist of an individual's objective ability and perceived self-efficacy to engage in adherence-related behavior (e.g., ability to take one's medications when one's daily routine changes; Fisher et al., 2006 Fisher et al., , 2008 .
The IMB model of ARV adherence is a mediational model, in which adherence-related information and motivation are seen to trigger the development and application of adherence-related behavioral skills to influence adherence behavior over time. Individuals who possess sufficient information and sufficient motivation Á but who lack necessary behavioral skills Á will be less likely to adhere effectively to their ARV regimen. Empirical support for the IMB model of adherence and the relationships among the specified constructs are available from correlational model-testing and experimental intervention research (e.g., Amico, Barta, et al., 2009; Amico, Toro-Alfonso, & Fisher, 2005; Fisher et al., 2006 Fisher et al., , 2008 Fisher et al., , 2010 Starace, Massa, Amico, & Fisher, 2006) . The current study examined the shared and unique adherence-related information, motivation, and behavioral skills barriers reported by intentionally (i.e., ''taking a break'') versus unintentionally (i.e., not ''taking a break'') non-adherent HIV-positive patients in clinical care settings.
Methods

Participants
The current study examined baseline data collected as part of a larger randomized controlled intervention trial Fisher et al., 2010) testing the efficacy of an IMB model-based ARV adherence support program for HIV-positive patients in clinical care. Participants were eligible for the study if they were HIV-positive, currently prescribed ARV medications, 18 years of age or older, and able to complete study requirements (i.e., free from substantial cognitive impairment or disability). Analyses for the present study were restricted to 327 HIV-positive participants (i.e., 54.7% of the 597 total participants enrolled at study baseline) who reported less than 100% adherence to their ARV medications on a modified Visual Analog Scale (VAS; Giordano, Guzman, Clark, Charlebois, & Bangsberg, 2004) . The research was approved by the Institutional Review Boards at the University of Connecticut and at each of the respective clinic study sites.
Procedure
Participants completed an assisted computeradministered self-interview (ACASI) with audio in English in a private area within one of five clinical care sites in Connecticut. The current study examined responses to the demographic items and to an IMB model-based ARV adherence barriers questionnaire, which were collected as part of the baseline assessment.
Measures
Demographic items
Demographic items included self-reports of age, gender, race/ethnicity, sexual orientation, years since HIV-positive diagnosis, history of injection drug use, employment status (e.g., unemployed, retired, employed part-time, and employed full-time), and housing status (e.g., stable versus unstable housing). Appropriate categorical and continuous response options were provided. These items were selected based on previous ARV-adherence studies (e.g., Amico, Barta, et al., 2009) .
LifeWindows InformationÁMotivationÁBehavioral Skills
Adherence Assessment Questionnaire (LW-IMB-AAQ) Psychosocial barriers to adherence-related behavior were assessed by the LifeWindows InformationÁ MotivationÁBehavioral Skills Adherence Assessment Questionnaire (LW-IMB-AAQ; LifeWindows Project Team, 2006), a 33-item measure assessing participants' adherence-related information, motivation, and behavioral skills. Each of the items on the LW-IMB-AAQ can be found in Tables 1Á3. Adherencerelated information was assessed with nine items measured on a five-point Likert-type scale (1 0 strongly disagree, 5 0strongly agree); adherencerelated motivation was assessed with 10 items measured on a five-point Likert-type scale (1 0strongly disagree, 5 0strongly agree); and adherence-related behavioral skills were assessed by 14 items on a fivepoint Likert-type scale (1 0very hard, 50very easy). Because we were interested in specific adherencerelated barriers characterizing intentional (i.e., ''taking a break'') and unintentional (i.e., not ''taking a break'') non-adherent patients, we examined each item-level barrier rather than summing or averaging items into aggregated scales.
ARV adherence
Patients' ARV medication adherence was assessed as part of the broader ACASI-delivered baseline questionnaire. Participants completed a 3Á4 week VAS assessment Giordano et al., 2004) , which was presented as a line ranging from 0 to 100%. Participants were asked to select a point along the continuum (which appeared in intervals of 10%) that reflected their average level of adherence during the past 3Á4 weeks for each prescribed medication ). An overall adherence score, representing the average level of adherence across each patient's medication(s), was used to characterize adherence rates among participants in the current study. For the current analysis, we opted to use participants' self-reports on the VAS rather than the modified three-day AIDS Clinical Trials Group (ACTG) adherence measure (Chesney et al., 2000) , in order to assess adherence rates over a longer period of time.
Intentional versus unintentional non-adherence A single item, ''Are you currently taking a break from your HIV medications without first talking with your healthcare provider?'' was developed for the present study and used to classify participants as intentional or unintentional non-adherers. Although the item did not specify a particular timeframe during which patients may have been ''taking a break,'' it did convey a sense of conscious awareness and volitional decision-making on behalf of the patient to deliberately alter or stop taking one's ARV regimen, which is consistent with previous classifications of intentional versus unintentional non-adherence behavior (e.g., Heath et al., 2002; Mo & Mak, 2009 ). Thus, participants who responded ''Yes'' to the ''taking a break'' item and who reported less than 100% adherence at study baseline (i.e., non-adherers) were classified as intentional non-adherers. Participants who responded ''No'' to the ''taking a break'' item and who reported less than 100% adherence at study baseline (i.e., non-adherers) were classified as unintentional non-adherers. Note that patients who were on a physician-initiated or prescribed discontinuation of ARVs were not included in the current analysis.
Data analysis
A series of one-way ANOVAs and Chi-square analyses examined differences between participants classified as intentional (i.e., ''taking a break'') versus unintentional (i.e., not ''taking a break'') non-adherers with respect to demographic variables and IMB model-based ARV adherence barriers. In order to control for a familywise Type I error that may result from multiple comparisons, statistical significance was set to p 50.01 (Bland & Altman, 1995; Holland & Copenhaver, 1988) . All analyses were conducted with PASW v. 17 (PASW Inc., 2009).
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Results
Patient characteristics
Of 327 HIV-positive patients with less than 100% adherence at baseline, 29 (8.9%) reported currently ''taking a break'' from their HIV medications without first talking with their healthcare provider. Thus, these 29 participants were classified as intentional non-adherers while 298 participants were classified as unintentional non-adherers. Table 4 summarizes basic demographic characteristics of the overall sample and within each non-adherence category. Chi-square analyses revealed only marginally significant differences between the groups with respect to race/ethnicity ( p00.06) and employment status ( p00.07; such differences must be interpreted with caution, however, due to relatively small cell sizes). No significant differences were observed between intentional versus unintentional non-adherent patients on other demographic variables.
Adherence-related information
A series of one-way ANOVAs corrected for familywise error examined differences with respect to adherence-related information between intentional versus unintentional non-adherers (1 0strongly disagree, 5 0strongly agree). As illustrated in Table 1 , only one difference was observed between the groups: intentional non-adherers (M 02.20, SD 01.56) were more likely to endorse the statement, ''As long as I am feeling healthy, missing my HIV medications from time to time is OK,'' compared to unintentional non-adherers (M 01.61, SD 01.14), F(1, 325) 06.64, p00.01. No other differences on information items were observed between the two groups.
Adherence-related motivation
A series of one-way ANOVAs corrected for familywise error examined differences between intentional versus unintentional non-adherers on each of 10 adherencerelated motivation items (1 0strongly disagree, 50strongly agree). As illustrated in Table 2 , only one item was significantly different between the groups: intentional non-adherers (M 03.75, SD 0 1.61) were more likely to endorse the statement, ''I get frustrated taking my HIV medications because I have to plan my life around them,'' compared to unintentional non-adherers (M02.92, SD 01.57), F(1, 325) 07.31, p00.007. Although not significant at the p50.01 level, differences were observed at p 5 0.02 before the correction on two additional items: intentional (versus unintentional) non-adherers reported greater difficulty taking medications because they remind them of their HIV-positive status, and intentional (versus unintentional) non-adherers reported greater frustration knowing that they have to take their HIV medications every day for the rest of their life.
Adherence-related behavioral skills
A series of one-way ANOVAs corrected for familywise error examined differences between intentional versus unintentional non-adherers on each of the 14 adherence-related behavioral skills items (1 0very hard, 5 0very easy). As illustrated in Table 3 
Discussion
In the current sample of 327 HIV-positive patients who reported less than 100% adherence to their ARV medications during the past 3Á4 weeks, 8.9% (n029) reported currently ''taking a break'' from their HIV medication(s) without first talking with their healthcare provider. Few differences were observed between participants classified as intentional (i.e., ''taking a break'') versus unintentional (i.e., not ''taking a break'') non-adherers on basic demographic variables, adherence-related information, or motivation. However, numerous differences were observed between groups on adherence-related behavioral skills. These preliminary findings highlight the potential utility of targeting such behavioral skills limitations in interventions directed at improving ARV adherence behavior among intentional non-adherent HIV-positive patients.
Results from the present study provide initial identification of the potentially unique psychosocial adherence-related barriers that may prevent intentional non-adherent HIV-positive patients from consistently adhering to their ARV medications. Interestingly, intentional versus unintentional nonadherent HIV-positive patients reported relatively similar levels of adherence-related information and motivation barriers, and differed with respect to only a few individual items. Among the adherence-related behavioral skills items, however, intentional nonadherent patients reporting greater levels of difficulty on approximately half of the behavioral skills items. This is consistent with the theoretical predictions of the IMB model of ARV adherence (Fisher et al., , 2008 , which specifies that deficits in behavioral skills constructs may thwart adherence even in the context of appropriate levels of adherence-related information and motivation. For some individuals, it appears that greater deficits in medication-taking behavioral skills may be associated with intentional non-adherent behavior.
Several limitations of the current study should be noted. First, patients' self-report on the ARV adherence questionnaire and ''taking a break'' behavior item may be subject to response bias. Procedural safeguards were implemented specifically to mitigate this effect (e.g., assessment of psychosocial adherence barriers and medication-taking behavior via ACASI software in a semi-private setting). Moreover, there is ample evidence to suggest that self-reported adherence is a reliable measure of actual adherence behavior (Oyugi et al., 2004; Simoni, Kurth, et al., 2006; Walsh, Mandalia, & Gazzard, 2002) . A second limitation of the present study is that causal inferences between ''taking a break'' behavior and behavioral skills barriers cannot be inferred due to the cross-sectional nature of the data. Results cannot speak to whether intentional nonadherence limits one's practical exposure to the behavior and produces deficits in skills secondary to lack of experience or exposure, or if deficiencies in behavioral skills cause adherence to be so arduous that individuals stop taking their dose. Longitudinal research is needed to examine temporal relations or to suggest some pattern of causality between behavioral skills deficits and ''taking a break,'' non-adherent behavior. Finally, the present study relied on a single-item response to classify patients as intentional or unintentional nonadherent. Although the percentage of patients classified (n03), multiple (n 010), and other (n07). b Categories for Chi-square analyses were restricted to homosexual and heterosexual due to small cell sizes. Additional responses included bisexual (n020), unsure (n03), or refuse to answer (n03). c Active IDU defined as having engaged in at least one injection use event within the past month. d Employed defined as working part-or full-time, compared to being unemployed, on disability or sick leave, or retired. e Stable housing defined as living in a friend/family's place or residence or in own residence compared to living on the street, in a homeless shelter, or in a halfway house.
as intentional non-adherers in the present study (i.e., 8.9%) is comparable to reports in other ARV adherence studies (i.e., 11%, Heath et al., 2002) , the single selfreport item may misclassify some patients as intentional or unintentional non-adherers, to the extent that patients may employ cognitive techniques to justify their behavior or fail to accurately acknowledge the source of their behavior, and thus incorrectly respond (and hence classify) themselves on the ''taking a break'' item. Future work is needed to explore this item as a valid measure of intentional versus unintentional nonadherent behavior, and may benefit from qualitative research that seeks to more fully understand HIVpositive patients' conceptualization, perception, and awareness of intentional versus unintentional nonadherent behavior. Despite these limitations, the current results point to the need for adherence-promotion programs to include skills-building and self-efficacy enhancing intervention modules in order to address ''taking a break'' behavior that could occur in about 10% of a clinic sample. Patients' decision-making in the volitional modification of prescribed regimens should be recognized more clearly in the literature and in practice. At minimum, some attention must be given at the intervention and clinical care level to foster open collaborative discussions with patients about plans to modify or experiences with intentionally altering one's prescribed ARV regimen, since patients in the present study reported ''taking a break'' without first discussing it with their healthcare provider. Based on the present findings, patient-provider discussions should also include an exploration of how limitations in behavioral skills may be influencing HIV-positive patients' conscious awareness of and decision to ''take a break'' from ARV medications.
